And in the first randomized trial (STOP-Vanc, 2026) the swab alone did not cut vancomycin days without an active prompt to stop
Zlatar, M., Kokot, A., Vuleti, L., Masnec, S., Kralj, T., Peria, M., Barii, I., Radi, B., Milanovi, K., Drmic, D., Seiwerth, S., & Sikiric, P
Your health takes priority over any awkwardness
Drug Interactions BPC-157 appears to interact with several medication classes, though most interactions are either neutral or potentially beneficial
Injectable BPC-157 Standard dose range: 200500 mcg per day Administration: Subcutaneous injection, once daily or split into two doses Cycle length: Typically 412 weeks, followed by an assessment period Injection site: Abdominal subcutaneous tissue
References Jastreboff AM, et al